Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eisai Wins U.S. Approval to Sell Drug Injected for Advanced Breast Cancer
Eisai Wins U.S. Approval to Sell Drug Injected for Advanced Breast Cancer
Eisai Wins U.S. Approval to Sell Drug Injected for Advanced Breast Cancer
Submitted by
admin
on November 15, 2010 - 6:26pm
Source:
Bloomberg
News Tags:
Eisai
breast cancer
FDA
Eribulin
Headline:
Eisai Wins U.S. Approval to Sell Drug Injected for Advanced Breast Cancer
Do Not Allow Advertisers to Use My Personal information
